Merck asks FDA to approve first COVID-19 antiviral pill
Oct 12, 2021
Molnupiravir could be major advance because it reaches more high-risk patients than the monoclonal antibody treatments now being used.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
U.S. to spend $3.2 billion to help develop antiviral pills for COVID-19
Jun 18, 2021
Oral medications patients take when symptoms first appear are being tested, but initial results are not expected for several months.
Biden to announce plan to battle omicron, delta variants this winter
Dec 02, 2021
The strategy will include free tests, extending rules on mask wearing and launching public awareness campaigns.
FDA panel mulls Merck COVID-19 antiviral pill
Nov 30, 2021
An expert panel will vote later Tuesday on whether to recommend authorizing the drug for high-risk patients.
Uptake low for monoclonal antibodies for COVID-19
Sep 22, 2021
Use peaked in January and declined in early 2021, at the time of the vaccine rollout.
US COVID-19 hospitalizations reach record low
May 30, 2023
Hospitalizations are among the few COVID-19 metrics still being monitored by public health officials.
U.S. to recommend booster shots for most Americans
Aug 17, 2021
The first boosters will be given to nursing home residents, healthcare workers and emergency workers. U.S. health officials are concerned as data from Israel continue to suggest that the Pfizer vaccine’s...
More batches of Moderna COVID-19 shots shipped amid reports of shortages
Sep 22, 2022
While supplies of the updated Pfizer booster shot appear to be plentiful, some pharmacies have reported not having enough Moderna vaccine.